Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2005 February;57(1) > Minerva Ginecologica 2005 February;57(1):79-86

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

  HUMAN REPRODUCTION


Minerva Ginecologica 2005 February;57(1):79-86

Copyright © 2005 EDIZIONI MINERVA MEDICA

language: English

Metabolic alterations and cardiovascular risk factors in the polycystic ovary syndrome

Pasquali R., Patton L., Pagotto U., Gambineri A.


PDF  


Available literature indicates that polycystic ovary syndrome (PCOS) represents a condition with a high prevalence of the metabolic syndrome, a greater and precocious appearance of glucose intolerance states, including type 2 diabetes mellitus, and a potentially greater risk for cardiovascular diseases. With respect to metabolic disorders, however, there is also emerging evidence that they are more prevalent in PCOS rather than in the general population, and that there are regional differences in the world, depending on lifestyle and other environmental factors. This evidence should be taken into consideration in future strategies focusing on prevention of metabolic and cardiovascular disorders in PCOS, not only on treatment of infertility and signs of androgen excess.

top of page

Publication History

Cite this article as

Corresponding author e-mail